progression following endocrine therapy, as well as for BC patients without prior endocrine therapy ( 15 ). Tamoxifen and fulvestrant have been used successfully for several years now and have led to a significant prolongation of progression-free survival as
Search Results
Jasmin Asberger, Thalia Erbes, Markus Jaeger, Gerta Rücker, Claudia Nöthling, Andrea Ritter, Kai Berner, Ingolf Juhasz-Böss, and Marc Hirschfeld
Matilde Calanchini, Michael Tadman, Jesper Krogh, Andrea Fabbri, Ashley Grossman, and Brian Shine
Introduction The incidence and prevalence of neuroendocrine neoplasms (NENs) has increased in recent years ( 1 , 2 ). Although improvements in diagnostic techniques and treatment modalities have led to improved survival and health
Malgorzata Fuksiewicz, Maria Kowalska, Agnieszka Kolasinska-Cwikla, and Beata Kotowicz
the possibility of using NSE determinations for estimating the degree of malignancy and the presence or absence of liver metastases. In the available publications, long-term follow-up of patients allowed the researchers to take overall survival time as
Enora Le Roux, Florence Menesguen, Isabelle Tejedor, Marc Popelier, Marine Halbron, Pauline Faucher, Sabine Malivoir, Graziella Pinto, Juliane Léger, Stephane Hatem, Michel Polak, Christine Poitou, and Philippe Touraine
exclude young people with an intellectual disability ( 13 ). Finally, the timing of data collection after patient transfer enables assessment of the short- and medium-term outcomes of the interventions, but rarely of longer-term ones ( 13 ). It is in
Stine A Holmboe, Ravi Jasuja, Brian Lawney, Lærke Priskorn, Niels Joergensen, Allan Linneberg, Tina Kold Jensen, Niels Erik Skakkebæk, Anders Juul, and Anna-Maria Andersson
Introduction Testosterone in serum is primarily bound to proteins with only a minor fraction circulating as free unbound testosterone. The major high-affinity binding protein is sex hormone-binding globulin (SHBG) ( 1 ). Because of the short
Sriharsha Gunna, Mahaveer Singh, Rakesh Pandey, Rungmei S K Marak, Amita Aggarwal, Bibhuti Mohanta, Liping Yu, and Eesh Bhatia
glucocorticoid treatment. Data on 29 patients with AH with a shorter follow-up have been reported earlier ( 10 ). All patients gave written informed consent, and the study was approved by the 105th Institutional Ethics Committee meeting of Sanjay Gandhi
Henrik H Thomsen, Holger J Møller, Christian Trolle, Kristian A Groth, Anne Skakkebæk, Anders Bojesen, Christian Høst, and Claus H Gravholt
. Baseline characteristics and levels of testosterone have been presented before (27) . As expected, no differences in parameters reflecting body composition were seen during short-term hypogonadism. Likewise, the concentrations of triglycerides (TGs), VLDL
Abdul K Siraj, Rong Bu, Maham Arshad, Kaleem Iqbal, Sandeep Kumar Parvathareddy, Tariq Masoodi, Laila Omar Ghazwani, Saif S Al-Sobhi, Fouad Al-Dayel, and Khawla S Al-Kuraya
( 36 ). Statistical analysis Contingency table analysis and Chi square tests were used to study the relationship between clinicopathological variables and protein expression. Disease-free survival curves were generated using the Kaplan
Yutong Zou, Lijun Zhao, Junlin Zhang, Yiting Wang, Yucheng Wu, Honghong Ren, Tingli Wang, Rui Zhang, Jiali Wang, Yuancheng Zhao, Chunmei Qin, Huan Xu, Lin Li, Zhonglin Chai, Mark E Cooper, Nanwei Tong, and Fang Liu
. Chi-squared or Fisher’s exact tests were used to compare the categorical variables. Kaplan–Meier survival analysis and Cox proportional hazards model were used to analyze the association between SUA quartiles and the renal outcomes. Three statistical
Jan-Bernd Stukenborg, Kirsi Jahnukainen, Marsida Hutka, and Rod T Mitchell
short-term cessation of spermatogenesis ( 54 ). Doses of 2–3 Gy also affect stem cell spermatogonia and cause long-term azoospermia. Doses in excess of 6 Gy are able to deplete the SSC pool and lead to permanent infertility ( 54 , 55 ). Fractionation of